Evidence for a terminal  -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney.
D000429:Alcohol Oxidoreductases; D001894:Borohydrides; D001923:Brain Chemistry; D002518:Ceramides / Q000032:analysis / Q000302:isolation & purification / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D005227:Fatty Acids / Q000032:analysis; D005690:Galactose / Q000032:analysis*; D005696:Galactosidases / Q000302:isolation & purification; D005732:Gangliosides / Q000032:analysis; D006017:Glycolipids / Q000032:analysis / Q000302:isolation & purification / Q000378:metabolism; D006027:Glycosides / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007536:Isomerism; D007668:Kidney / Q000032:analysis* / Q000378:metabolism; D008052:Lipid Metabolism, Inborn Errors / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008722:Methods; D009844:Oligosaccharides / Q000032:analysis; D009904:Optical Rotation; D010084:Oxidation-Reduction; D011725:Pyridines; D013107:Sphingolipids / Q000032:analysis; D013696:Temperature; D014316:Tritium
D001894:Borohydrides; D002518:Ceramides; D005227:Fatty Acids; D005732:Gangliosides; D006017:Glycolipids; D006027:Glycosides; D009844:Oligosaccharides; D011725:Pyridines; D013107:Sphingolipids; D014316:Tritium; D000429:Alcohol Oxidoreductases; D005696:Galactosidases; D005690:Galactose